SCHEMBL1376729

SCHEMBL1376729

N#Cc1cccc(C(NCCNC(=O)O)C(c2cccnc2)c2cccnc2)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 5/20 0.46
VNN1 O95497 2/20 0.44
KCNH2 Q12809 2/20 0.41
CYP19A1 P11511 1/20 0.41
MGLL Q99685 1/20 0.41
CTSL P07711 1/20 0.39
CTSS P25774 1/20 0.39
CTSK P43235 1/20 0.39
SGMS2 Q8NHU3 1/20 0.39
NAMPT P43490 1/20 0.38
GRM5 P41594 2/20 0.38
BRAF P15056 1/20 0.38
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
EPHX2 P34913 1/20 0.37
GPR139 Q6DWJ6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1243189 0.85 CYP19A1 (0.46) KCNA5VNN1KCNH2CYP19A1MGLL
SCHEMBL1242218 0.85 KCNA5 (0.45) KCNA5VNN1CYP19A1MGLLCTSS
SCHEMBL1243799 0.83 KCNA5 (0.55) KCNA5VNN1KCNH2CYP19A1MGLL
SCHEMBL1242304 0.83 KCNA5 (0.47) KCNA5VNN1KCNH2CYP19A1MGLL
SCHEMBL9903713 0.82 KCNA5 (0.46) KCNA5VNN1KCNH2CYP19A1MGLL
SCHEMBL4580519 0.81 SMN1; SMN2 (0.47) KCNA5VNN1SGMS2NAMPTCYP2C9
SCHEMBL1243076 0.81 KCNA5 (0.46) KCNA5VNN1KCNH2CYP19A1MGLL
SCHEMBL9903840 0.80 KCNA5 (0.44) KCNA5VNN1KCNH2CYP19A1MGLL
SCHEMBL9903845 0.80 KCNA5 (0.44) KCNA5VNN1KCNH2CYP19A1MGLL
SCHEMBL1242307 0.80 KCNA5 (0.48) KCNA5VNN1KCNH2CYP19A1MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4719745-B2 2011-07-06 JP claimed
EP-1781635-A4 POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2009-02-25 EP claimed
EP-1781635-A2 POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2007-05-09 EP claimed
WO-2006015159-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2006-02-09 WO claimed